Why Most Medical AI Tools Fail Researchers (And What Actually Works)
We have had the same conversation more times than we can count. A researcher tried a tool, stopped using it within weeks, and can explain exactly why. The explanations are remarkably consistent.
We have had a version of the same conversation more times than we can count. A researcher, usually someone who considers themselves reasonably open to new tools, tells us they tried an AI product, sometimes a well-funded, well-marketed one, and stopped using it within a few weeks. When we ask why, the answers cluster around a small number of themes.
The tool was impressive in the demo and unreliable in practice. It produced outputs that sounded authoritative but could not be verified. It did not understand the specificity of their domain. It saved time on tasks they did not need help with and was useless on the ones they actually cared about. It felt like it had been built for a researcher that does not exist, some generic knowledge worker, rather than for the specific, technically demanding work they were actually doing.
These are not complaints about AI in general. They are complaints about a specific generation of tools that were rushed to market before the product thinking had caught up with the technology. Understanding what went wrong is useful, because it points directly at what actually works.
The demo problem
AI tools for research have a structural demo problem. They are built on language models that are fluent, confident, and broad, properties that produce impressive demonstrations and that break down in specific, predictable ways under real working conditions.
In a demo, a researcher asks a broad question and receives a well-structured, plausible-sounding answer. The demo ends before the researcher has a chance to verify the citations, probe the edge cases, or test the tool on the specific questions they actually need answered day to day. The fluency of the output is mistaken for the reliability of the underlying system.
The gap between demo performance and daily usability is wider in medical research than in most other domains, because the domain is highly specialised, the stakes of errors are high, and the questions researchers need answered are often highly specific. A tool that handles general questions about diabetes well may be useless on the specific question about a metabolic pathway variant in a particular patient population that a researcher actually needs to understand this week.
The citation fabrication problem
This one has been well documented but is worth addressing directly because it has done real damage to researcher trust in AI tools. Large language models, when asked to support a claim with references, sometimes generate citations that do not exist, plausible-looking paper titles, real-sounding author names, genuine journal names, specific volume and page numbers. All fabricated.
This is not a minor bug. In medical research, a fabricated citation is not just an embarrassment, it is a potential patient safety issue if it influences clinical practice, and a potential research integrity issue if it finds its way into a published paper. Researchers who discovered fabricated citations in AI outputs, often after having nearly used them, did not go back to those tools.
The solution is architectural, not cosmetic. Tools that generate citations from a verified, indexed corpus and that show you the actual source text rather than a generated summary of it do not have this problem. Tools that generate citations from a language model's parametric memory, from what it learned during training rather than from a live database, will always have it to some degree. Knowing which kind of tool you are using matters enormously.
The generalist problem
The earliest AI tools marketed to researchers were general-purpose language models with a research-flavoured interface. They could help with any writing task, answer questions on any topic, and summarise documents of any kind. The breadth was the point.
The problem is that medical research is not a general domain. It has specific methodological standards, specific reporting requirements, specific vocabulary, specific quality hierarchies in the evidence base. A tool that does not understand the difference between a randomised controlled trial and an observational study, or that treats a preprint and a peer-reviewed meta-analysis as equivalent sources, is not a research tool. It is a writing assistant that has been renamed.
The tools that are actually useful to serious medical researchers are the ones that have been built with the domain in mind, that understand what a systematic review is, that know what PICO means, that can assess the methodological quality of a study rather than just summarising its abstract.
The workflow integration problem
Even well-designed tools fail if they require researchers to change their workflows significantly to use them. A tool that lives outside the environments where research actually happens, that requires exporting files, re-entering data, or switching contexts at inconvenient points in the process, gets abandoned, not because it is bad but because the friction cost exceeds the value at the moments when it matters.
This is a product problem more than a technology problem, and it is one that the best tools in this space take seriously. The goal is to be present at the moments where the researcher needs help, in the format that is actually useful at that moment, not to require the researcher to adapt their process to the tool's architecture.
What actually works
The tools that researchers keep using, the ones that become part of the workflow rather than a failed experiment, share a set of characteristics that are worth stating directly.
They are honest about what they do not know. When the evidence is uncertain, they say so. When a question is outside the scope of reliable output, they say that too. The willingness to say "I cannot give you a reliable answer to this" is a sign of a tool designed for real use rather than for demos.
They show their sources. Every claim is traceable to specific papers that can be verified. The researcher never has to take the tool's word for anything, they can always go back to the primary source and check.
They are specific to the domain. They understand medical research methodology, not just medical terminology. They can engage with questions about study design, evidence quality, and methodological limitations in ways that are useful to someone who knows what those things mean.
And they are built around the researcher's judgment rather than as a replacement for it. The best AI tools in medical research are the ones that the researcher is still clearly in charge of, that augment their capacity to engage with the literature without making decisions for them or obscuring the basis for what they are showing.
We built NousLab around these principles because they are what the researchers we spoke to actually needed. Not because they are the easiest principles to build around, they are not, but because tools built without them do not get used. And a tool that does not get used has not solved anything. See what those principles look like in practice.
